1. |
Cavazzana-CalvoM, Andr?-Schmutz I, Dal Cortivo L, et al. Immune reconstitutionafter haematopoietic stem cell transplantation: obstacles and anticipatedprogress. Curr Opin Immunol 2009; 21:544-8.
|
2. |
Sport鑣 C,Hakim FT, Memon SA, et al. Administration of rhIL -7 inhumans increases invivo TCR repertoire diversity by preferential expansion of naive T cellsubsets. J Exp Med 2008; 205:1701-14.
|
3. |
Mackall CL. Enhancingimmune reconstitution after stem cell transplants with cytokines. Cytotherapy 2002; 4: 427-8.
|
4. |
SeggewissR, Lor? K, Guenaga FJ, et al. Keratinocyte growth factor augments immunereconstitution after autologous hematopoietic progenitor cell transplantationin rhesus macaques. Blood 2007; 110:441-9.
|
5. |
Chen BJ,Cui X, Sempowski GD, et al. Growth hormone accelerates immune recoveryfollowing allogeneic T-cell- depleted bone marrow transplantation in mice. ExpHematol2003; 31:953-8.
|
6. |
AmroliaPJ, Mucioli-Casadei G, Huls H, et al. Add-back of allodepleted donor T cells toimprove immune reconstitution after haplo-identical stem cell transplantation.Cytotherapy2005; 7:116-25.
|
7. |
Morecki S, Paniqrahi S, Pizov G, et al. Effect of KRN7000 oninduced graft-vs-host disease.ExpHematol 2004; 32: 630-7.
|
8. |
Hashimoto D, Asakura S, Miyake S, et al. Stimulation of hostNKT cells by synthetic glycolipid regulates acute graft-versus-host disease byinducing Th2 polarization of donor T cells. J Immunol 2005; 174:551-6.
|
9. |
Haraquchi K, Takahashi T, Matsumoto A, et al. Host-residualinvariant NKT cells attenuate graft-versus-host immunity. J Immunol 2005;175:1320-8.
|
10 |
Hong C, Lee H, Park YK, et al. Regulation of secondary antigen-specific CD8(+) T-cellresponses by natural killer T cells. Cancer Res2009;69:4301-8.
|
11 |
Tonti E,Galli G, Malzone C, et al. NKT-cell help to B lymphocytes can occurindependently of cognate interaction. Blood 2009; 113:370-6.
|
12 |
Kuns RD,Morris ES, Macdonald KP, et al. Invariant natural killer T cell-natural killercell interactions dictate transplantation outcome afteralpha-galactosylceramide administration. Blood 2009; 113:5999-6010.
|
13 |
Kojo S, Seino K, Harada M, et al. Inductionof regulatory properties in dendritic cells by Valpha14 NKT cells. J Immunol 2005; 175:3648-55.
|
14 |
Kotsianidis I, Silk JD, Spanoudakis E, et al. Regulation ofhematopoiesis in vitro and in vivo by invariant NKT cells. Blood2006; 107:3138-44.
|
15 |
Kuwatani M, Ikarashi Y, Iizuka A, et al. Modulation of acutegraft-versus-host disease and chimerism after adoptive transfer of in vitro-expandedinvariant Valpha14 natural killer T cells. Immunol Lett 2006; 106:82-90.
|
16 |
LacerdaJF. Immunologic reconstitution after allogeneic stem cell transplant. Acta MedPort 2004; 17:471-80.
|
17 |
Lapidot T,Dar A, Kollet O. How do stem cells find their way home? Blood 2005;106:1901-10.
|
18 |
Kunii N, Horiguchi S, Motohashi S, et al. Combination therapy of in vitro-expanded natural killer T cells and alpha-galactosylceramide-pulsedantigen-presenting cells in patients with recurrent head and neck carcinoma. Cancer Sci 2009; 100:1092-8.
|